Ivan V. Korendovych

Ivan V. Korendovych is a Professor and holds the James R. Schofield Endowed Chair in Biochemistry at Baylor University, where he joined in 2024. He previously served at Syracuse University as Assistant Professor (2011–2017), Associate Professor (2017–2021), and Professor and Associate Chair of the Chemistry Department (2021–2023). His academic journey began with B.S. and M.S. degrees from National Taras Shevchenko University of Kiev, followed by a Ph.D. from Tufts University in 2006, and postdoctoral training at the University of Pennsylvania Medical School.

• Ph.D., Tufts University, 2006
• M.S. & B.S., National Taras Shevchenko University of Kiev, 2000 & 1999
• Postdoctoral Fellow, University of Pennsylvania Medical School, 2006–2011

His research centers on protein engineering, biocatalysis, and chemical biology. He pioneers the development of catalytic amyloids from short peptides, designs minimalist de novo enzymes using single reactive residues, and creates novel fluorescent probes like AzAla for studying protein interactions with minimal environmental interference. His work bridges fundamental enzymology with practical applications in biosensing and synthetic biology.

The published articles reflect a strong trajectory in designing functional biomolecules, particularly catalytic peptides and engineered proteins. The research spans biocatalysis, fluorescence-based probing, and protein design, with consistent publication in top-tier journals. Key themes include enzyme mimicry, allosteric regulation, and the use of non-natural amino acids.

While no specific scientific awards are mentioned in the text, his work has been published in prestigious journals such as Nature Chemistry, JACS, and Angewandte Chemie, indicating significant peer recognition.

Ivan V. Korendovych leads the Korendovych Lab, where he mentors students and postdoctoral researchers in cutting-edge projects involving peptide self-assembly, enzyme design, and fluorescent probe development. His collaborations extend internationally, including with Prof. Jaap Broos at the University of Groningen, focusing on in vivo incorporation of non-natural amino acids. Future work is likely to expand on catalytic amyloids, allosteric control in synthetic enzymes, and the application of AzAla in complex biological systems.